These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 8874257)
41. Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure. Conraads VM; Denollet J; De Clerck LS; Stevens WJ; Bridts C; Vrints CJ Int J Cardiol; 2006 Oct; 113(1):34-8. PubMed ID: 16325284 [TBL] [Abstract][Full Text] [Related]
42. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function. Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179 [TBL] [Abstract][Full Text] [Related]
43. Different characteristics of chronic heart failure (CHF) in elderly diabetics and non-diabetics. Romeo R; Scalisi C; Tafuri L; Romeo A; Maugeri D; Sorace R Arch Gerontol Geriatr; 2010; 50(1):101-4. PubMed ID: 19371958 [TBL] [Abstract][Full Text] [Related]
44. The importance of tumor necrosis factor and lipoproteins in the pathogenesis of chronic heart failure. Sharma R; Al-Nasser FO; Anker SD Heart Fail Monit; 2001; 2(2):42-7. PubMed ID: 12634890 [TBL] [Abstract][Full Text] [Related]
45. Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failure. Anker SD; Volterrani M; Egerer KR; Felton CV; Kox WJ; Poole-Wilson PA; Coats AJ QJM; 1998 Mar; 91(3):199-203. PubMed ID: 9604072 [TBL] [Abstract][Full Text] [Related]
46. Effective nocturnal oxygen therapy increases circulating level of tumor necrosis factor-alpha in heart failure. Guzzetti S; Fundarò C; Pecis M; Costantino G; Marchetti G; Meroni L J Cardiovasc Med (Hagerstown); 2008 Jan; 9(1):64-7. PubMed ID: 18268422 [TBL] [Abstract][Full Text] [Related]
47. Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium? Ceconi C; Curello S; Bachetti T; Corti A; Ferrari R Prog Cardiovasc Dis; 1998; 41(1 Suppl 1):25-30. PubMed ID: 9715820 [TBL] [Abstract][Full Text] [Related]
48. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of SADKO-CHF study). Part 2]. Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN Ter Arkh; 2006; 78(9):61-71. PubMed ID: 17076227 [TBL] [Abstract][Full Text] [Related]
49. Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure. Kourea K; Parissis JT; Farmakis D; Panou F; Paraskevaidis I; Venetsanou K; Filippatos G; Kremastinos DT Atherosclerosis; 2008 Jul; 199(1):215-21. PubMed ID: 17991471 [TBL] [Abstract][Full Text] [Related]
50. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers. George J; Patal S; Wexler D; Abashidze A; Shmilovich H; Barak T; Sheps D; Keren G Arch Intern Med; 2005 Jun; 165(11):1304-9. PubMed ID: 15956012 [TBL] [Abstract][Full Text] [Related]
52. [Cytokines and remodeling of the heart in patients with congestive heart failure]. Jołda-Mydłowska B; Salomon P Pol Arch Med Wewn; 2003 Jan; 109(1):23-33. PubMed ID: 12879763 [TBL] [Abstract][Full Text] [Related]
53. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure]. Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578 [TBL] [Abstract][Full Text] [Related]
54. Relationship between plasma atrial natriuretic factor and opioid peptide levels in healthy subjects and in patients with acute congestive heart failure. Fontana F; Bernardi P; Pich EM; Capelli M; Bortoluzzi L; Spampinato S; Canossa M Eur Heart J; 1993 Feb; 14(2):219-25. PubMed ID: 8095454 [TBL] [Abstract][Full Text] [Related]
55. Diagnostic and prognostic utility of measuring tumor necrosis factor in the peripheral circulation of patients with immune-mediated sensorineural hearing loss. Svrakic M; Pathak S; Goldofsky E; Hoffman R; Chandrasekhar SS; Sperling N; Alexiades G; Ashbach M; Vambutas A Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1052-8. PubMed ID: 23165380 [TBL] [Abstract][Full Text] [Related]
56. Disturbance of circulating ghrelin and obestatin in chronic heart failure patients especially in those with cachexia. Xin X; Ren AJ; Zheng X; Qin YW; Zhao XX; Yuan WJ; Guo ZF Peptides; 2009 Dec; 30(12):2281-5. PubMed ID: 19666068 [TBL] [Abstract][Full Text] [Related]
57. The relationship between age and production of tumour necrosis factor-alpha in healthy volunteers and patients with chronic heart failure. von Haehling S; Genth-Zotz S; Sharma R; Bolger AP; Doehner W; Barnes PJ; Coats AJ; Anker SD Int J Cardiol; 2003 Aug; 90(2-3):197-204. PubMed ID: 12957752 [TBL] [Abstract][Full Text] [Related]
58. Blood ketone bodies in congestive heart failure. Lommi J; Kupari M; Koskinen P; Näveri H; Leinonen H; Pulkki K; Härkönen M J Am Coll Cardiol; 1996 Sep; 28(3):665-72. PubMed ID: 8772754 [TBL] [Abstract][Full Text] [Related]
59. Increased expression of tumor necrosis factor-alpha converting enzyme and tumor necrosis factor-alpha in peripheral blood mononuclear cells in patients with advanced congestive heart failure. Satoh M; Iwasaka J; Nakamura M; Akatsu T; Shimoda Y; Hiramori K Eur J Heart Fail; 2004 Dec; 6(7):869-75. PubMed ID: 15556048 [TBL] [Abstract][Full Text] [Related]
60. Inflammatory mediators in Chinese patients with congestive heart failure. Wang Y; Zhou Y; Meng L; Lu X; Ou N; Li X J Clin Pharmacol; 2009 May; 49(5):591-9. PubMed ID: 19398605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]